日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bioinspired and stimuli-responsive nanocomposites for targeted therapy in ovarian and endometrial tumors

用于卵巢癌和子宫内膜肿瘤靶向治疗的仿生刺激响应型纳米复合材料

Yao, Jihang; Liu, Lulu; Teng, Xiufei; Chu, Daming; Ding, Silu; Li, Hui; Chang, Hua; Liu, Jing

Medical irregular multivariate time series forecasting based on multi-scale temporal-frequency domain patch fusion and dynamic graph

基于多尺度时频域块融合和动态图的医学异常多元时间序列预测

Liu, Xueping; Gong, Tianyi; Li, Youru; Li, Na; Ding, Silu

Advances in hybrid hydrogel design for biomedical applications: innovations in drug delivery and tissue engineering for gynecological cancers

用于生物医学应用的混合水凝胶设计进展:妇科癌症药物递送和组织工程的创新

Chang, Hua; Wei, Heng; Qi, Yue; Ding, Silu; Li, Hui; Si, Si

Predictive framework for cervical cancer brachytherapy fractionation mode integrating generative model and dynamic feature aggregation GNNs

基于生成模型和动态特征聚合图神经网络的宫颈癌近距离放射治疗分次模式预测框架

Liu, Xueping; Liu, Xingya; Li, Youru; Bai, Shi; Li, Na; Gong, Tianyi; Ding, Silu

Molecular mechanism of tumor-infiltrating immune cells regulating endometrial carcinoma

肿瘤浸润免疫细胞调控子宫内膜癌的分子机制

Ding, Silu; Hao, Yingying; Qi, Yue; Wei, Heng; Zhang, Jin; Li, Hui

Comparison of post-chemoradiotherapy pneumonitis between Asian and non-Asian patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis

亚洲及非亚洲局部晚期非小细胞肺癌患者放化疗后肺炎的比较:系统评价和荟萃分析

Liu, Tingting; Li, Sihan; Ding, Silu; Qiu, Jingping; Ren, Chengbo; Chen, Jun; Wang, He; Wang, Xiaoling; Li, Guang; He, Zheng; Dang, Jun

UNC5A, an epigenetically silenced gene, functions as a tumor suppressor in non-small cell lung cancer.

UNC5A 是一种表观遗传沉默的基因,在非小细胞肺癌中发挥抑癌基因的作用

Ding Silu, Zhang Hongwei, Zhao Xinyu, Dang Jun, Li Guang

Elective nodal irradiation versus involved-field irradiation in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a network meta-analysis

食管癌新辅助放化疗患者选择性淋巴结照射与受累野照射的比较:一项网络荟萃分析

Liu, Tingting; Ding, Silu; Dang, Jun; Wang, Hui; Chen, Jun; Li, Guang

First-line immune checkpoint inhibitors for advanced non-small cell lung cancer with wild-type epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK): a systematic review and network meta-analysis

一线免疫检查点抑制剂治疗具有野生型表皮生长因子受体(EGFR)或间变性淋巴瘤激酶(ALK)的晚期非小细胞肺癌:系统评价和网络荟萃分析

Liu, Tingting; Ding, Silu; Dang, Jun; Wang, Hui; Chen, Jun; Li, Guang